The MEPs Against Cancer (MAC) Interest Group was founded in 2005 by a group of MEPs, and remains the only dedicated group for cancer policy at the European Parliament. MAC work together in order to improve cancer control and prevention in Europe, in the belief that European cooperation adds value to member state actions.
In the 2019-24 parliamentary legislature, MAC has 136 members coming from different political groups and EU Member States. The Chairs, Dr. Véronique Trillet-Lenoir (RE, France) and Mr. Loucas Fourlas (EPP, Cyprus), Vice-Chairs Mr. Rory Palmer (S&D, United Kingdom) and Dr. Petra de Sutter (Greens/EFA, Belgium), and other members are committed to taking action in the fight against cancer.
Quotes from the Chairs
‘It is a great honour for me to be elected as a Chair of this group, which is the only dedicated group on cancer policy in the European Parliament at this moment. My vision was realized with the signing of the Manifesto Against Cancer, which aims to formulate policies with key pillars of activity prevention, ensuring high quality treatment for all patients and involvement of them in formulating health policies.
My participation in this group today is a statement of my intention to work with all my strengths on cancer issues with a particular emphasis on paediatric oncology and paediatric palliative care. I am seeking to claim as much funding as possible for the development of strategic partnerships, innovative methods and tools that will effectively and working all together to reach our goals as a real team consisted of a big number of dedicated MEPs from all the political groups of the European Parliament.’
“For more than 30 years, I have dedicated my work as a University Professor and Public Service Medical Doctor to the fight against cancer, the leading cause of death in Europe and a subject of great suffering for millions of citizens. I am therefore very proud to become Chair of the MAC Group.
The 4 million people affected in Europe need a European strategy to fight against cancer. A collective and concerted strategy is required in our Parliament to promote and support efforts to improve prevention, research, access to innovation and reintegration and reduce health inequalities among citizens.
We need the European scale to guarantee access to the most innovative medicines without shortage, and at a fair price, to mobilize more research teams on ambitious programs for the Cancer Horizon Europe Mission and to fight against rare cancers and in particular paediatric cancers that still kill 6000 children per year.
I therefore welcomed with great enthusiasm the proposal for a European plan to beat cancer in the political guidelines of the President of the European Commission, Mrs Ursula Von der Leyen and of the Commissioner-designate for Health, Mrs. Stella Kyriakides. With my experience as a Clinician, Teacher and Researcher, as well as President of a French Cancer cluster and Administrator of the French National Cancer Institute, I am ready to commit in this program and mobilize Members of the European Parliament as well as all stakeholders, particularly patients’ representatives, around this noble cause for Europe.’
The Association of European Cancer Leagues (ECL) is honoured to have been appointed by MAC to provide secretarial support. ECL is a Brussels‐based non‐profit organisation who represents national cancer societies across Europe. If you would like to become a member of MAC and make a difference in cancer control, receive more information about our initiatives or organise and event with MAC MEPs, please visit www.mepsagainstcancer.eu or contact us at MAC(at)europeancancerleagues.org.